Pricing & Access· August 8, 2026 · 14 min read
Novo Nordisk portfolio dossier (Q2 2026): Wegovy, CagriSema & obesity pipeline
By Ran Chen#Novo Nordisk#Semaglutide#Wegovy
Topic
Wegovy
Semaglutide 2.4 mg injection (Wegovy) coverage, prior authorization, formulary status, cardiovascular and MASH indications, and payer access criteria.
Specialty· June 6, 2026 · 14 min read
GLP-1 benefit investigation: verify coverage, PA, and specialty pharmacy
Specialty· June 6, 2026 · 15 min read
GLP-1 specialty pharmacy mandatory routing: when your pharmacy can't fill the prescription
By Ran Chen#GLP-1#Specialty Pharmacy#Pharmacy Benefit
Specialty· June 6, 2026 · 16 min read
GLP-1 step therapy exception: document contraindication and prior-therapy failure
By Ran Chen#GLP-1#Step Therapy#Prior Authorization
Pricing & Access· June 6, 2026 · 9 min read